A registered study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · PREVENTION · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 43
- Population
- ALL · 60 Years to 85 Years
- Duration
- 2024-01-29 to 2027-06-30
- Intervention
- Bright Light Therapy (AYO Glasses)
- Comparator
- BLT control; BLT intervention
- Outcomes measured
- Sleep quality — Change from baseline to endpoint at 12 weeks; Short Physical Performance Battery — Change from baseline to endpoint at 12 weeks; Frailty assessment — Change from baseline to endpoint at 12 weeks; Gait speed — Change from baseline to endpoint at 12 weeks; Muscle strength — Change from baseline to endpoint at 12 weeks; Body Composition (Lean and fat mass) — Change from baseline to endpoint at 12 weeks; Interleukin-6 — Change from baseline at 12 weeks; Sleep quantity — Change from baseline at 12 weeks; Step counts — Change from baseline to endpoint at 12 weeks; Cognitive screen - SLUMS — Change from baseline to endpoint at 12 weeks; Brain Derived Neurotrophic Factor (BDNF) — Change from baseline to endpoint at 12 weeks; Sleepiness — Change from baseline at 12 weeks; Fatigue — Change from baseline at 12 weeks; Sleep disorders — Change from baseline at 12 weeks; Amyloid beta 42/40 ratio — Change from baseline at 12 weeks; Cognitive screen - Cognivue — Change from baseline at 12 weeks; Sleep stages — Change from baseline to endpoint at 12 weeks; Phosphorylated tau (P-tau) — Change from baseline at 12 weeks; Interleukin-10 — Change from baseline at 12 weeks; Insomnia — Change from baseline at 12 weeks
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.